NIAID Site Search

As global temperatures rise, it has become more urgent to understand the interactions between climate, mosquitoes, and the pathogens mosquitoes transmit to humans. NIAID Now spoke to Luis Chaves, Ph.D., a 2023 Scholar with the National Institutes of Health (NIH) Climate Change and Health Initiative, about his work about the impacts of environmental change on the ecology of insect vectors and the diseases they transmit.

Published: August 18, 2023

A drug approved to treat certain autoimmune diseases and cancers successfully alleviated symptoms of a rare genetic syndrome called autoimmune polyendocrine syndrome type 1 (APS-1).

Published: May 30, 2024

Last Reviewed: August 6, 2024

Sample application from David Al-Adra MD, Ph.D., for NIH standard independent research project grant (K08).

Last Reviewed: September 13, 2024

Last Reviewed: November 24, 2023

Sample application from Nicole Putnam, Ph.D., for National Research Service Award (NRSA) individual fellowship (F31) grants.

Last Reviewed: January 25, 2023

Office of Research on Women’s Health and NIH Support for Research on Women’s Health Report of the Advisory Committee on Research on Women’s Health: Fiscal Years 2019–2020 508-compliant PDF

Last Reviewed: March 8, 2022

Sample application from Mohammad Ayoub Mir

Last Reviewed: August 4, 2017

Sample application from Kenneth Coleman, Ph.D., for Small Business Innovation Research (SBIR) fast track grant.

Last Reviewed: November 25, 2022

Vector-Borne Diseases Systems Ecology in the Context of Climate Change: Understanding Transmission of Arthropod-Borne Pathogens Across Biological & Ecological Scales

Last Reviewed: September 1, 2023

Jordan Report: Accelerated Development of Vaccines (2002) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: December 31, 2002

Jordan Report: Accelerated Development of Vaccines (2007) from NIAID includes updates on vaccine research for specific infectious diseases.

Last Reviewed: August 6, 2019

National Institutes of Health // Food and Drug Administration // Immunology Interest Group

Last Reviewed: October 6, 2022

Dr. Barry received his Ph.D. in organic and bio-organic chemistry in 1989 from Cornell University. He joined NIAID following postdoctoral research at Johns Hopkins University. In 1998, he was tenured as chief of the TBRS. Dr. Barry is a member of several editorial boards, has authored more than 300 research publications in tuberculosis, and is the most cited researcher in the field, according to ScienceWatch.com.

Last Reviewed: January 12, 2024

TBRS is a multidisciplinary group composed of chemists, microbiologists, veterinarians, imaging scientists, and clinicians with a shared objective of improving chemotherapy for tuberculosis (TB) patients. Projects span chemical biology, medicinal chemistry, host-pathogen interactions, animal models of experimental chemotherapy, and experimental medicine clinical studies in TB patients.

Last Reviewed: March 11, 2025

The 206 th meeting of the National Advisory Allergy and Infectious Diseases Council (NAAIDC) convened virtually at 10:30 a.m. on Tuesday, January 30, 2024. Dr. Jeanne Marrazzo, Director, National Institute of Allergy and Infectious Diseases (NIAID) presided as chair. In accordance with the provisions of Public Law 92-463, the meeting was open to the public from 10:30 a.m. to 11:45 a.m. and from 1

Last Reviewed: May 21, 2024